Melissa Fowler
Physician Assistant · Tucson, AZNPI 1629334271
Payments from drug & device makers
Across 331 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- UCB, Inc.$1K
- Amgen$1K
- Pfizer$481
- Organon$384
- AstraZeneca$375
- plus $2K from 20 others
What the payments were for
- Food & beverage$7,373100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $1,403 |
| UCB, Inc. | 50 | $1,345 |
| Amgen | 69 | $1,290 |
| Pfizer | 27 | $481 |
| Organon | 19 | $384 |
| AstraZeneca(2 entities) | 19 | $375 |
| Boehringer Ingelheim | 9 | $299 |
| Radius Health, Inc. | 13 | $280 |
| Sanofi | 10 | $264 |
| Lilly USA, LLC | 13 | $242 |
| Johnson & Johnson | 7 | $222 |
| Octapharma USA, Inc. | 5 | $138 |
| Mallinckrodt Hospital Products Inc. | 4 | $121 |
| E.r. Squibb & Sons, L.L.C. | 5 | $96 |
| Novartis | 3 | $72 |
| Bioventus LLC | 2 | $71 |
| Sobi, Inc | 2 | $59 |
| Sandoz | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $31 |
| GSK | 2 | $30 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Mylan Institutional Inc. | 1 | $23 |
| Celltrion USA Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
| ANI Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$7,373 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $124,618 |
| TymlosAbaloparatide | 20 | $58,239 |
| OtezlaApremilast | 11 | $51,508 |
| Hydroxychloroquine Sulfate | 138 | $5,354 |
| MethotrexateMethotrexate Sodium | 165 | $4,406 |
| Colchicine | 18 | $2,149 |
| Prednisone | 212 | $1,516 |
| Sulfasalazine | 35 | $1,095 |
| Duloxetine Hcl | 45 | $907 |
| Leflunomide | 24 | $706 |
| Celecoxib | 35 | $556 |
| Folic Acid | 42 | $304 |
| Ibuprofen | 16 | $229 |
| Alendronate Sodium | 23 | $219 |
| Baclofen | 12 | $177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $280 | $58,23920 claims |
| AmgenOtezla | $1,290 | $51,50811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Tucson
- Nicole StokerTucson$61K
- Robert HoyTucson$41K
- Luis LozanoTucson$31K
- Christy HallTucson$30K
- Monica MettilleTucson$27K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.